Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol for Preventing Post-Operative Delirium
NCT02213900Phase 4Completed
- Sponsor
- Indiana University
- Start
- Sep 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in delirium comparing Haloperidol with Placebo (2 arms). Primary endpoint: Efficacy of Low-dose Haloperidol in Reducing Delirium Incidence up to 30 days. Started Sep 2013; status: completed.
02
Drugs
haloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on NCT02213900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02213900.